Skip to search formSkip to main contentSkip to account menu

Nasonex

Known as: nasal nasonex spray, nasonex nasal spray 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

MometasoneMometasone furoate monohydratemometasone furoate
mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Novel Simulation-Based Approach for Comparing the Population Against Average Bioequivalence Statistical Test for the Evaluation of Nasal Spray Products on Spray Pattern and Droplet Size…
The aim of this work is to evaluate average bioequivalence (ABE) and population bioequivalence (PBE) statistical approaches so as… 
2017
2017
[The role of topical glucocorticoids in the treatment of rhinosinusitis].
The guidelines of the European position paper on rhinosinusitis and nasal polyps (EPOS, 2012) ascribe the highest strength and… 
2016
2016
First generic Nasonex available
FDA recently approved the first generic version of Nasonex nasal spray (mometasone furoate monohydrate, Apotex Corp). 
Review
2008
Review
2008
[Patient preference survey on the lack of taste and odor of Nasonex nasal spray. Which impact on compliance to treatment?].
In order to assess the acceptability of a new scent-free formulation of mometasone furoate (Nasonex) among allergic rhinitis… 
2008
2008
Enquête de préférence patients sur l'absence de saveur et d'odeur du Nasonex en pulvérisation nasale. Quel impact sur l'observance du traitement ?
Afin d'evaluer l'acceptabilite d'une nouvelle formule sans parfum de Nasonex aupres de patients allergiques deja traites par… 
2003
2003
A clinical observation on the therapeutic effect of combined therapy with nasonex and bimin formula on allergic rhinitis
Objective To investigate the therapeutic effect of a combined therapy with Na-sonex and Bimin Formula(BF) on allergic rhinitis… 
1999
1999
Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis.
BACKGROUND Mometasone furoate nasal spray (MFNS, NASONEX ), is a new synthetic corticosteroid with considerable efficacy in the… 
1998
1998
[The efficacy of a new medication -- intranasal glucocorticoid mometasone furoate (Nasonex) -- in seasonal allergic rhinitis].
The aim of this open study was to evaluate the efficacy and safety of new topical corticosteroid Nasonex (mometasone furoate) in… 
1998
1998
Open study of the efficacy and safety of Nasonex a new intranasal glucocorticosteroid in seasonal allergic rhinitis
1991
1991
NASONEX, method for manufacturing the same and pharmaceutical compositions.
The invention relates to a novel compound mometasone Monohydrate methasone, a process for their preparation and pharmaceutical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)